Barclays PLC Morphic Holding, Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Barclays PLC holds 44,727 shares of MORF stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,727

Previous 130,387 65.7%

Holding current value

$1.52 Million

Previous $3.77 Million 58.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $2.28 Million - $3.45 Million	-85,660 Reduced 65.7%	44,727 $1.58 Million
Q4 2023 Feb 15, 2024	BUY	$19.95 - $31.0 $1.12 Million - $1.75 Million	56,389 Added 76.2%	130,387 $3.77 Million
Q3 2023 Nov 07, 2023	BUY	$21.33 - $59.42 $149,395 - $416,177	7,004 Added 10.45%	73,998 $1.7 Million
Q2 2023 Aug 03, 2023	BUY	$34.33 - $62.11 $1.23 Million - $2.22 Million	35,718 Added 114.2%	66,994 $3.84 Million
Q1 2023 May 04, 2023	SELL	$26.01 - $48.69 $810,263 - $1.52 Million	-31,152 Reduced 49.9%	31,276 $1.18 Million

Q4 2022 Feb 13, 2023	BUY	$24.14 - $30.37 $78,696 - $99,006	3,260 Added 5.51%	62,428 $1.67 Million
Q3 2022 Nov 03, 2022	BUY	$22.23 - $33.37 $1.29 Million - $1.93 Million	57,877 Added 4483.11%	59,168 $1.68 Million
Q2 2022 Aug 12, 2022	SELL	$19.74 - $43.01 $45,856 - $99,912	-2,323 Reduced 64.28%	1,291 $28,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $800,073 - $1.15 Million	-22,071 Reduced 85.93%	3,614 $145,000
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $698,767 - $1.06 Million	16,149 Added 169.35%	25,685 $1.22 Million
Q3 2021 Nov 09, 2021	BUY	$53.61 - $67.5 $214,011 - $269,460	3,992 Added 72.01%	9,536 $540,000
Q2 2021 Aug 13, 2021	SELL	$45.13 - $64.99 $275,293 - $396,438	-6,100 Reduced 52.39%	5,544 $318,000
Q1 2021 May 13, 2021	BUY	$29.77 - $84.85 $212,766 - $606,422	7,147 Added 158.93%	11,644 $737,000
Q4 2020 Feb 11, 2021	SELL	$25.66 - $34.55 $45,854 - $61,740	-1,787 Reduced 28.44%	4,497 $151,000
Q3 2020 Nov 12, 2020	SELL	$22.51 - $30.11 $28,092 - $37,577	-1,248 Reduced 16.57%	6,284 $172,000
Q2 2020 Aug 12, 2020	BUY	$12.65 - $29.57 $50,258 - $117,481	3,973 Added 111.63%	7,532 $203,000
Q1 2020 May 13, 2020	SELL	$10.84 - $20.85 $15,024 - $28,898	-1,386 Reduced 28.03%	3,559 $52,000
Q4 2019 Feb 10, 2020	BUY	$13.02 - $19.5 $30,050 - $45,006	2,308 Added 87.52%	4,945 $85,000
Q3 2019 Nov 14, 2019	BUY	$17.46 - $29.05 $46,042 - $76,604	2,637 New	2,637 $48,000

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account